nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.123	0.915	CbGbCtD
Niacin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0113	0.0843	CbGbCtD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.00499	0.0394	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00321	0.0253	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.00307	0.0242	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00304	0.024	CbGpPWpGaD
Niacin—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—COX2—peripheral nervous system neoplasm	0.00281	0.0222	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00244	0.0193	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.00235	0.0186	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00234	0.0185	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00232	0.0183	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00222	0.0175	CbGpPWpGaD
Niacin—QPRT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00207	0.0164	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00193	0.0153	CbGpPWpGaD
Niacin—NNMT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00193	0.0152	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00186	0.0147	CbGpPWpGaD
Niacin—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00182	0.0143	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00181	0.0143	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00172	0.0136	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00158	0.0125	CbGpPWpGaD
Niacin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—COX2—peripheral nervous system neoplasm	0.00152	0.012	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.0015	0.0119	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00144	0.0114	CbGpPWpGaD
Niacin—QPRT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.0014	0.0111	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00138	0.0109	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00137	0.0108	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00131	0.0103	CbGpPWpGaD
Niacin—NNMT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.0013	0.0103	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00125	0.0099	CbGpPWpGaD
Niacin—QPRT—Disease—GNS—peripheral nervous system neoplasm	0.00121	0.00955	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.0012	0.00949	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00119	0.00938	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.00114	0.00902	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00114	0.00899	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.0011	0.00866	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00105	0.00826	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00104	0.00821	CbGpPWpGaD
Niacin—QPRT—Metabolism—GNS—peripheral nervous system neoplasm	0.00101	0.008	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000992	0.00783	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000982	0.00775	CbGpPWpGaD
Niacin—QPRT—Metabolism—NME1—peripheral nervous system neoplasm	0.000971	0.00767	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00096	0.00758	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00095	0.0075	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000944	0.00745	CbGpPWpGaD
Niacin—NNMT—Metabolism—GNS—peripheral nervous system neoplasm	0.000942	0.00744	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000942	0.00744	CbGpPWpGaD
Niacin—QPRT—Metabolism—COX2—peripheral nervous system neoplasm	0.000935	0.00738	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00091	0.00718	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000906	0.00715	CbGpPWpGaD
Niacin—NNMT—Metabolism—NME1—peripheral nervous system neoplasm	0.000903	0.00713	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.0009	0.00711	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000877	0.00692	CbGpPWpGaD
Niacin—NNMT—Metabolism—COX2—peripheral nervous system neoplasm	0.000869	0.00686	CbGpPWpGaD
Niacin—QPRT—Disease—PPP3R1—peripheral nervous system neoplasm	0.000846	0.00668	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000831	0.00656	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00079	0.00624	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000775	0.00612	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00074	0.00585	CbGpPWpGaD
Niacin—QPRT—Disease—ENO2—peripheral nervous system neoplasm	0.000733	0.00579	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00071	0.0056	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000702	0.00554	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000687	0.00542	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000673	0.00531	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000636	0.00502	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00062	0.0049	CbGpPWpGaD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.000617	0.00487	CbGpPWpGaD
Niacin—QPRT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000614	0.00485	CbGpPWpGaD
Niacin—QPRT—Disease—SLC2A1—peripheral nervous system neoplasm	0.000591	0.00466	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000588	0.00464	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000574	0.00453	CbGpPWpGaD
Niacin—NNMT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000571	0.0045	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000563	0.00445	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000561	0.00443	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000551	0.00435	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00055	0.00434	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000542	0.00428	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000534	0.00421	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000532	0.0042	CbGpPWpGaD
Niacin—QPRT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000519	0.00409	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000518	0.00409	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000514	0.00406	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00051	0.00402	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00051	0.00402	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000509	0.00402	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000503	0.00397	CbGpPWpGaD
Niacin—QPRT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000495	0.00391	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000492	0.00389	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000491	0.00388	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000489	0.00386	CbGpPWpGaD
Niacin—QPRT—Metabolism—TH—peripheral nervous system neoplasm	0.000488	0.00385	CbGpPWpGaD
Niacin—NNMT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000482	0.00381	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00048	0.00379	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000467	0.00369	CbGpPWpGaD
Niacin—NNMT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00046	0.00363	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GNS—peripheral nervous system neoplasm	0.00046	0.00363	CbGpPWpGaD
Niacin—NNMT—Metabolism—TH—peripheral nervous system neoplasm	0.000453	0.00358	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000446	0.00352	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NME1—peripheral nervous system neoplasm	0.000441	0.00348	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000438	0.00346	CbGpPWpGaD
Niacin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000435	0.000588	CcSEcCtD
Niacin—Rash—Topotecan—peripheral nervous system neoplasm	0.000435	0.000588	CcSEcCtD
Niacin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000434	0.000588	CcSEcCtD
Niacin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000434	0.000587	CcSEcCtD
Niacin—Cough—Etoposide—peripheral nervous system neoplasm	0.000433	0.000585	CcSEcCtD
Niacin—Headache—Topotecan—peripheral nervous system neoplasm	0.000432	0.000584	CcSEcCtD
Niacin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000431	0.000583	CcSEcCtD
Niacin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000431	0.000583	CcSEcCtD
Niacin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000431	0.000583	CcSEcCtD
Niacin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000431	0.000583	CcSEcCtD
Niacin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000431	0.000583	CcSEcCtD
Niacin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000431	0.000583	CcSEcCtD
Niacin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000429	0.000581	CcSEcCtD
Niacin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000429	0.00058	CcSEcCtD
Niacin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000428	0.00058	CcSEcCtD
Niacin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000428	0.00058	CcSEcCtD
Niacin—Pain—Vincristine—peripheral nervous system neoplasm	0.000427	0.000578	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.000578	CcSEcCtD
Niacin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000427	0.000578	CcSEcCtD
Niacin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000576	CcSEcCtD
Niacin—Rash—Melphalan—peripheral nervous system neoplasm	0.000426	0.000576	CcSEcCtD
Niacin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000425	0.000575	CcSEcCtD
Niacin—SLC16A3—Hemostasis—HGF—peripheral nervous system neoplasm	0.000425	0.00335	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—COX2—peripheral nervous system neoplasm	0.000424	0.00335	CbGpPWpGaD
Niacin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.000573	CcSEcCtD
Niacin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000572	CcSEcCtD
Niacin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000421	0.00057	CcSEcCtD
Niacin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000421	0.00057	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000421	0.00332	CbGpPWpGaD
Niacin—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000569	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000419	0.000567	CcSEcCtD
Niacin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000413	0.000558	CcSEcCtD
Niacin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000558	CcSEcCtD
Niacin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000412	0.000557	CcSEcCtD
Niacin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000412	0.000557	CcSEcCtD
Niacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.000554	CcSEcCtD
Niacin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.000554	CcSEcCtD
Niacin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00041	0.000554	CcSEcCtD
Niacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000408	0.000553	CcSEcCtD
Niacin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000551	CcSEcCtD
Niacin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000406	0.00055	CcSEcCtD
Niacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000406	0.00055	CcSEcCtD
Niacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000405	0.000547	CcSEcCtD
Niacin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000402	0.000544	CcSEcCtD
Niacin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000543	CcSEcCtD
Niacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000401	0.000543	CcSEcCtD
Niacin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000401	0.000543	CcSEcCtD
Niacin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000399	0.00054	CcSEcCtD
Niacin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000399	0.00054	CcSEcCtD
Niacin—QPRT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000398	0.00314	CbGpPWpGaD
Niacin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000397	0.000537	CcSEcCtD
Niacin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000395	0.000534	CcSEcCtD
Niacin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000395	0.000534	CcSEcCtD
Niacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000395	0.000534	CcSEcCtD
Niacin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000533	CcSEcCtD
Niacin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000394	0.000533	CcSEcCtD
Niacin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000393	0.000532	CcSEcCtD
Niacin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000529	CcSEcCtD
Niacin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000391	0.000529	CcSEcCtD
Niacin—QPRT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000391	0.00308	CbGpPWpGaD
Niacin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000528	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000389	0.00307	CbGpPWpGaD
Niacin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000526	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000386	0.00305	CbGpPWpGaD
Niacin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000386	0.000522	CcSEcCtD
Niacin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000384	0.000519	CcSEcCtD
Niacin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000519	CcSEcCtD
Niacin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000382	0.000518	CcSEcCtD
Niacin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000382	0.000517	CcSEcCtD
Niacin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000381	0.000516	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000379	0.00299	CbGpPWpGaD
Niacin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000378	0.000512	CcSEcCtD
Niacin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000378	0.000511	CcSEcCtD
Niacin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000509	CcSEcCtD
Niacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.000503	CcSEcCtD
Niacin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000503	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000371	0.00293	CbGpPWpGaD
Niacin—NNMT—Metabolism—GNAS—peripheral nervous system neoplasm	0.00037	0.00292	CbGpPWpGaD
Niacin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000499	CcSEcCtD
Niacin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000499	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000369	0.00291	CbGpPWpGaD
Niacin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000368	0.000498	CcSEcCtD
Niacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.000496	CcSEcCtD
Niacin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000363	0.000492	CcSEcCtD
Niacin—NNMT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000363	0.00287	CbGpPWpGaD
Niacin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000361	0.000488	CcSEcCtD
Niacin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00036	0.000487	CcSEcCtD
Niacin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000486	CcSEcCtD
Niacin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000358	0.000485	CcSEcCtD
Niacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000355	0.000481	CcSEcCtD
Niacin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.00048	CcSEcCtD
Niacin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000355	0.00048	CcSEcCtD
Niacin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000352	0.000477	CcSEcCtD
Niacin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000352	0.000476	CcSEcCtD
Niacin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000349	0.000473	CcSEcCtD
Niacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000349	0.000472	CcSEcCtD
Niacin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000469	CcSEcCtD
Niacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000469	CcSEcCtD
Niacin—Pain—Etoposide—peripheral nervous system neoplasm	0.000346	0.000468	CcSEcCtD
Niacin—SLC16A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000344	0.00271	CbGpPWpGaD
Niacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000343	0.000464	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000342	0.0027	CbGpPWpGaD
Niacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000342	0.000462	CcSEcCtD
Niacin—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000461	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000333	0.00263	CbGpPWpGaD
Niacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000332	0.000449	CcSEcCtD
Niacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000331	0.000448	CcSEcCtD
Niacin—QPRT—Disease—PTPN11—peripheral nervous system neoplasm	0.00033	0.00261	CbGpPWpGaD
Niacin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00033	0.000447	CcSEcCtD
Niacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.000446	CcSEcCtD
Niacin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.000442	CcSEcCtD
Niacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.000442	CcSEcCtD
Niacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000325	0.00044	CcSEcCtD
Niacin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.000439	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000324	0.00256	CbGpPWpGaD
Niacin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000321	0.000435	CcSEcCtD
Niacin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000434	CcSEcCtD
Niacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000434	CcSEcCtD
Niacin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000434	CcSEcCtD
Niacin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000433	CcSEcCtD
Niacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00032	0.000433	CcSEcCtD
Niacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00032	0.000433	CcSEcCtD
Niacin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000432	CcSEcCtD
Niacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000432	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.00043	CcSEcCtD
Niacin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000318	0.00043	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000317	0.0025	CbGpPWpGaD
Niacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000317	0.000429	CcSEcCtD
Niacin—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000427	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000315	0.00249	CbGpPWpGaD
Niacin—Rash—Vincristine—peripheral nervous system neoplasm	0.000315	0.000426	CcSEcCtD
Niacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000315	0.000426	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000425	CcSEcCtD
Niacin—Headache—Vincristine—peripheral nervous system neoplasm	0.000313	0.000423	CcSEcCtD
Niacin—SLC16A3—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.00031	0.00245	CbGpPWpGaD
Niacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.000417	CcSEcCtD
Niacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000416	CcSEcCtD
Niacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000302	0.000409	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000301	0.00237	CbGpPWpGaD
Niacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000404	CcSEcCtD
Niacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000298	0.000403	CcSEcCtD
Niacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000403	CcSEcCtD
Niacin—SLC16A1—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000297	0.00234	CbGpPWpGaD
Niacin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000402	CcSEcCtD
Niacin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000297	0.000401	CcSEcCtD
Niacin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000401	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000401	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.0004	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.0004	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000398	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000291	0.0023	CbGpPWpGaD
Niacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000394	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000291	0.0023	CbGpPWpGaD
Niacin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00029	0.000393	CcSEcCtD
Niacin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000392	CcSEcCtD
Niacin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000388	CcSEcCtD
Niacin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000286	0.000387	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000386	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000385	CcSEcCtD
Niacin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000382	CcSEcCtD
Niacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000281	0.00038	CcSEcCtD
Niacin—SLC16A3—Metabolism—ENO2—peripheral nervous system neoplasm	0.000279	0.0022	CbGpPWpGaD
Niacin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000377	CcSEcCtD
Niacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000376	CcSEcCtD
Niacin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000376	CcSEcCtD
Niacin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000376	CcSEcCtD
Niacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000277	0.000375	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000373	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000276	0.00218	CbGpPWpGaD
Niacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000373	CcSEcCtD
Niacin—SLC16A1—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000275	0.00217	CbGpPWpGaD
Niacin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000371	CcSEcCtD
Niacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00037	CcSEcCtD
Niacin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000369	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000271	0.00214	CbGpPWpGaD
Niacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000365	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000363	CcSEcCtD
Niacin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000268	0.000362	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000361	CcSEcCtD
Niacin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000359	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000357	CcSEcCtD
Niacin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000262	0.000355	CcSEcCtD
Niacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000354	CcSEcCtD
Niacin—QPRT—Disease—ERBB2—peripheral nervous system neoplasm	0.000261	0.00206	CbGpPWpGaD
Niacin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000353	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000259	0.00204	CbGpPWpGaD
Niacin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000257	0.000348	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000348	CcSEcCtD
Niacin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000348	CcSEcCtD
Niacin—Rash—Etoposide—peripheral nervous system neoplasm	0.000255	0.000345	CcSEcCtD
Niacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000255	0.000345	CcSEcCtD
Niacin—Headache—Etoposide—peripheral nervous system neoplasm	0.000253	0.000343	CcSEcCtD
Niacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000343	CcSEcCtD
Niacin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000341	CcSEcCtD
Niacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000338	CcSEcCtD
Niacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000338	CcSEcCtD
Niacin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000337	CcSEcCtD
Niacin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000337	CcSEcCtD
Niacin—SLC16A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000248	0.00196	CbGpPWpGaD
Niacin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000334	CcSEcCtD
Niacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000332	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00033	CcSEcCtD
Niacin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000328	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000328	CcSEcCtD
Niacin—SLC16A1—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000241	0.0019	CbGpPWpGaD
Niacin—Nausea—Etoposide—peripheral nervous system neoplasm	0.00024	0.000325	CcSEcCtD
Niacin—SLC16A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000238	0.00188	CbGpPWpGaD
Niacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000237	0.00032	CcSEcCtD
Niacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000237	0.00032	CcSEcCtD
Niacin—SLC16A3—Metabolism—BCHE—peripheral nervous system neoplasm	0.000235	0.00186	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000318	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000235	0.00185	CbGpPWpGaD
Niacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000313	CcSEcCtD
Niacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000313	CcSEcCtD
Niacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000312	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000311	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00023	0.00182	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HGF—peripheral nervous system neoplasm	0.000229	0.00181	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000229	0.00181	CbGpPWpGaD
Niacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000307	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000307	CcSEcCtD
Niacin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000307	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000306	CcSEcCtD
Niacin—SLC16A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000225	0.00177	CbGpPWpGaD
Niacin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000304	CcSEcCtD
Niacin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000302	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000223	0.00176	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TH—peripheral nervous system neoplasm	0.000221	0.00175	CbGpPWpGaD
Niacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000299	CcSEcCtD
Niacin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000298	CcSEcCtD
Niacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000297	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000296	CcSEcCtD
Niacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000296	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000294	CcSEcCtD
Niacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000292	CcSEcCtD
Niacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00029	CcSEcCtD
Niacin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000287	CcSEcCtD
Niacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000284	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000284	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000208	0.00164	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000207	0.00028	CcSEcCtD
Niacin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000279	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000206	0.00162	CbGpPWpGaD
Niacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000278	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000277	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000204	0.00161	CbGpPWpGaD
Niacin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000276	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000276	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000274	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000274	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000202	0.0016	CbGpPWpGaD
Niacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000273	CcSEcCtD
Niacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000271	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00027	CcSEcCtD
Niacin—QPRT—Disease—NRAS—peripheral nervous system neoplasm	0.000199	0.00157	CbGpPWpGaD
Niacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000267	CcSEcCtD
Niacin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000265	CcSEcCtD
Niacin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000265	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000195	0.00154	CbGpPWpGaD
Niacin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000262	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000192	0.00151	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000259	CcSEcCtD
Niacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000257	CcSEcCtD
Niacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000255	CcSEcCtD
Niacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000253	CcSEcCtD
Niacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000252	CcSEcCtD
Niacin—SLC16A3—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000186	0.00147	CbGpPWpGaD
Niacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000251	CcSEcCtD
Niacin—QPRT—Disease—MYC—peripheral nervous system neoplasm	0.000185	0.00146	CbGpPWpGaD
Niacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00025	CcSEcCtD
Niacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000247	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000245	CcSEcCtD
Niacin—SLC16A3—Metabolism—GNAS—peripheral nervous system neoplasm	0.000181	0.00143	CbGpPWpGaD
Niacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000244	CcSEcCtD
Niacin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000243	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000243	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000243	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000179	0.00141	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000177	0.0014	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000176	0.00139	CbGpPWpGaD
Niacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000232	CcSEcCtD
Niacin—SLC16A1—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000167	0.00132	CbGpPWpGaD
Niacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000226	CcSEcCtD
Niacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000226	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000224	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000224	CcSEcCtD
Niacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.00022	CcSEcCtD
Niacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000217	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00016	0.00126	CbGpPWpGaD
Niacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00021	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000209	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000151	0.0012	CbGpPWpGaD
Niacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000204	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000151	0.00119	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00015	0.00119	CbGpPWpGaD
Niacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000203	CcSEcCtD
Niacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000201	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000146	0.00116	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—peripheral nervous system neoplasm	0.000145	0.00115	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000145	0.00114	CbGpPWpGaD
Niacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000195	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000194	CcSEcCtD
Niacin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000193	CcSEcCtD
Niacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000193	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000143	0.00113	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—peripheral nervous system neoplasm	0.000142	0.00112	CbGpPWpGaD
Niacin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000192	CcSEcCtD
Niacin—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000142	0.00112	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000139	0.0011	CbGpPWpGaD
Niacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000188	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000137	0.00109	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000136	0.00108	CbGpPWpGaD
Niacin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000182	CcSEcCtD
Niacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000181	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000133	0.00105	CbGpPWpGaD
Niacin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000179	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000179	CcSEcCtD
Niacin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000178	CcSEcCtD
Niacin—QPRT—Disease—AKT1—peripheral nervous system neoplasm	0.000128	0.00101	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000127	0.001	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000126	0.000995	CbGpPWpGaD
Niacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000169	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000122	0.00096	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000121	0.000958	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—peripheral nervous system neoplasm	0.00012	0.00095	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TH—peripheral nervous system neoplasm	0.00012	0.000944	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000115	0.00091	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000113	0.000894	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—peripheral nervous system neoplasm	0.000107	0.000848	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000107	0.000847	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000101	0.000794	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—peripheral nervous system neoplasm	9.99e-05	0.000789	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNAS—peripheral nervous system neoplasm	9.76e-05	0.00077	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.58e-05	0.000756	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.57e-05	0.000755	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.3e-05	0.000734	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.89e-05	0.000702	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.82e-05	0.000696	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.43e-05	0.000666	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.85e-05	0.00062	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—peripheral nervous system neoplasm	7.69e-05	0.000607	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.44e-05	0.000588	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—peripheral nervous system neoplasm	7.36e-05	0.000581	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	6.92e-05	0.000546	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	6.63e-05	0.000524	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—peripheral nervous system neoplasm	6.5e-05	0.000513	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	6.39e-05	0.000504	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—peripheral nervous system neoplasm	4.88e-05	0.000385	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	4.19e-05	0.000331	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.54e-05	0.00028	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.38e-05	0.000267	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	3.33e-05	0.000263	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.72e-05	0.000215	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.67e-05	0.000211	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.63e-05	0.000208	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	7.34e-06	5.79e-05	CbGpPWpGaD
